# Randomized Directly Observed Therapy Study to Interpret Clinical Trials of Doxy-PEP

> **NCT06414408** · EARLY_PHASE1 · RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 48 (estimated)

## Conditions studied

- Sexually Transmitted Diseases, Bacterial

## Interventions

- **DRUG:** Doxycycline Pill

## Key facts

- **NCT ID:** NCT06414408
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-18
- **Primary completion:** 2026-09-01
- **Final completion:** 2028-09-01
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06414408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06414408, "Randomized Directly Observed Therapy Study to Interpret Clinical Trials of Doxy-PEP". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06414408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*